Subscribe
Contact Us
About Us
Advertise
Home
News
News from MM&M
Off the Wire
Newsletters
PMD Profiles
Agency Creative Showcase
Publication Connection
PMD Marketplace
Careers
About Us
Additional Resources
MM&M
MM&M Jobs
MAHF
Voi Consulting
Advertise
Subscribe
Get Listed
Additional Resources
RSS
|
Login
|
Register
Home
> Off the Wire
Off the Wire
Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
March 11, 2010
Findings will Contribute to Understanding and Future Study of Figitumumab
Neoprobe Announces Successful Meeting on Lymphoseek Phase 3 Results
March 11, 2010
Submission Plan for New Drug Application for Lymphoseek Reviewed With FDA
Portola Pharmaceuticals Announces Senior Management and Board Changes
March 11, 2010
Charles Homcy, M.D. to retire May 1, 1010
Affymax® Receives $5 Million Milestone Payment on Initiation of Phase 3 Clinical Trials for Hematide in Japan
March 10, 2010
Affymax and Takeda will co-commercialize the product in the U.S.
Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens
March 10, 2010
Premium Lens Provides Medicare Beneficiaries With New Option
Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
March 09, 2010
Abbott will acquire Facet for $27 per share in cash
Lilly to Acquire European Rights to Pfizer Animal Health Assets
March 08, 2010
Deal Provides Strategic Fit For Elanco, Lilly's Animal Health Division
Alun Malone Joins Millennium Laboratories As New Business Development Executive
March 08, 2010
Mr. Malone brings knowledge and experience in the therapeutic drug monitoring industry
CSL Behring Receives FDA Approval of Hizentra™
March 04, 2010
First 20 Percent Subcutaneous Immunoglobulin Therapy
Columbia Laboratories Enters into Purchase and Collaboration Agreement with Watson Pharmaceuticals for Progesterone Franchise
March 04, 2010
Watson to acquire rights to CRINONE® and PROCHIEVE®
more »
News from Medical Marketing & Media
Covidien, Biovail to beef up sales forces
Physician referral directory revamped for 2010
WebMD launches social networking venture
PhRMA to DDMAC: Let my people tweet
GSK launches surprising cervical cancer ads
AMA to help docs cash in on EHR stimulus dollars
Smart phones and apps proliferate among docs, surveys say
DTC spending stabilized in 2009 amid strong growth for cable, Internet adspend
Xyzal campaign to give allergies a 'Clean Sweep'
Publicis launches Razorfish Health as standalone
more »
Most Popular
Most Emailed
Most Recent
Columbia Laboratories Enters into Purchase and Collaboration Agreement with Watson Pharmaceuticals for Progesterone Franchise
FDA Approves Exalgo Extended-Release Tablets
Astellas Pharma Inc. Commences Tender Offer to Acquire All Outstanding Shares of OSI Pharmaceuticals for $52 per Share in Cash
Transdel Pharmaceuticals Appoints Terry Nida as Chief Business Officer
CSL Behring Receives FDA Approval of Hizentra™
Shire Announces FDA Approval of VPRIV(TM) (velaglucerase alfa for injection) for the Treatment of Type 1 Gaucher Disease
EKR Therapeutics Appoints John Bailye as Interim President & Chief Executive Officer
Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer's Disease Clinical Development Program
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
FDA Advisory Committee Recommends Approval Of XIFAXAN® (rifaximin) Tablets, 550 Mg for Maintenance of Remission of Hepatic Encephalopathy
Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Neoprobe Announces Successful Meeting on Lymphoseek Phase 3 Results
Portola Pharmaceuticals Announces Senior Management and Board Changes
Affymax® Receives $5 Million Milestone Payment on Initiation of Phase 3 Clinical Trials for Hematide in Japan
Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens
Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
Lilly to Acquire European Rights to Pfizer Animal Health Assets
Alun Malone Joins Millennium Laboratories As New Business Development Executive
Portola Pharmaceuticals Announces Senior Management and Board Changes
Neoprobe Announces Successful Meeting on Lymphoseek Phase 3 Results
Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech
Abbott Receives U.S. FDA Approval for New Cataract Multifocal Intraocular Lens
Affymax® Receives $5 Million Milestone Payment on Initiation of Phase 3 Clinical Trials for Hematide in Japan
Alun Malone Joins Millennium Laboratories As New Business Development Executive
Lilly to Acquire European Rights to Pfizer Animal Health Assets
CSL Behring Receives FDA Approval of Hizentra™
EKR Therapeutics Appoints John Bailye as Interim President & Chief Executive Officer
Popular Topics
Acquisition
Agency
Animal Health
Biopharmaceutical
Biotech
Business
Clinical Management
Collaboration
Marketing & Communications
Medical Device
Medical Equipment
Merger
New Company
New Hire
New Hires
Personnel
Pharmaceutical
Pharmaceutical Marketplace
Pharmaceutical Products
Pipeline
Product Acquisition
Product Launch
Product Promotion
Regulatory
Research & Development